Greg Tourangeau

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Gregory Tourangeau
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Greg Tourangeau:

Company Role Class Num Shares Value Price $ Report Date Ownership
Fulcrum Therapeutics, Inc. Principal Accounting Officer Common Stock 14,062 $71,153 $5.06 08 May 2025 Direct
Fulcrum Therapeutics, Inc. Principal Accounting Officer Stock Option (right to buy) 57,000 02 Feb 2026 Direct

Insider Reports Filed by Greg Tourangeau

Symbol Company Period Transactions Value $ Form Type Role Filing Time
FULC Fulcrum Therapeutics, Inc. 02 Feb 2026 1 $0 4 Principal Accounting Officer 04 Feb 2026, 16:10
FULC Fulcrum Therapeutics, Inc. 08 May 2025 1 -$2,520 4 Principal Accounting Officer 09 May 2025, 16:15
FULC Fulcrum Therapeutics, Inc. 24 Jan 2025 1 $0 4 Principal Accounting Officer 28 Jan 2025, 16:15
FULC Fulcrum Therapeutics, Inc. 07 May 2024 1 -$1,831 4 Principal Accounting Officer 09 May 2024, 16:10
FULC Fulcrum Therapeutics, Inc. 08 Mar 2024 1 -$57,219 4 Vice President, Finance 08 Mar 2024, 18:05
FULC Fulcrum Therapeutics, Inc. 26 Jan 2024 2 $0 4 Vice President, Finance 30 Jan 2024, 21:10
FULC Fulcrum Therapeutics, Inc. 10 May 2023 1 -$695 4 Principal Accounting Officer 11 May 2023, 16:12
FULC Fulcrum Therapeutics, Inc. 09 Feb 2023 1 $0 4 Controller 13 Feb 2023, 15:15
FULC Fulcrum Therapeutics, Inc. 15 Jul 2022 1 $0 4 Controller 19 Jul 2022, 16:15
FULC Fulcrum Therapeutics, Inc. 06 May 2022 2 $0 4 Controller 10 May 2022, 16:15
FULC Fulcrum Therapeutics, Inc. 11 Mar 2022 0 $0 3 Controller 14 Mar 2022, 16:15